Dermatologists' Educational Demonstration for Epiduo Application
This trial is active, not recruiting.
|Conditions||facial acne, local adverse effects|
|Treatments||epiduo once daily with detailed instruction for how to apply it, epiduo- once daily, simple instruction for application, bpo once daily|
|Sponsor||Seoul National University Hospital|
|Start date||March 2014|
|End date||September 2014|
|Trial size||65 participants|
|Trial identifier||NCT02192632, 1402-051-555, ADP-BPO|
The purpose of this study is to evaluate the efficacy and tolerability of this combination gel compared with BPO monotherapy in Korean patients, and test clinical practicability of dermatologists' educational demonstration for how to apply this gel in reducing uncomfortable irritations.
|Endpoint classification||safety/efficacy study|
|Intervention model||parallel assignment|
|Masking||single blind (investigator)|
Percentile reduction of non-inflammatory & inflammatory acne lesions
time frame: 12 weeks
Total number of local irriation effect counts (erythema, scaling, dryness, itching)
time frame: 12 week
Male or female participants from 18 years up to 40 years old.
Inclusion Criteria: - mild to moderate acne were evaluated by Leeds revised acne grade from 2 to 6 - age: 18-40 Exclusion Criteria: - pregnancy - mental illness - intake of oral isotretinoin within 6 months - application of the other oral or topical acne medications - chemical peeling or light based treatments within 6 weeks.
Call for more information